174 related articles for article (PubMed ID: 11372762)
1. Morphological diagnoses of the Japan adult leukemia study group acute myeloid leukemia protocols: central review.
Kuriyama K; Tomonaga M; Kobayashi T; Takeuchi J; Ohshima T; Furusawa S; Saitoh K; Ohno R;
Int J Hematol; 2001 Jan; 73(1):93-9. PubMed ID: 11372762
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 study.
Miyazaki Y; Kuriyama K; Miyawaki S; Ohtake S; Sakamaki H; Matsuo T; Emi N; Kobayashi T; Matsushima T; Shinagawa K; Ohno R; Tomonaga M;
Br J Haematol; 2003 Jan; 120(1):56-62. PubMed ID: 12492577
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.
Roberson JR; Onciu M; Pounds S; Rubnitz JE; Pui CH; Razzouk BI
Pediatr Blood Cancer; 2008 Mar; 50(3):542-8. PubMed ID: 17763467
[TBL] [Abstract][Full Text] [Related]
4. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD).
Taguchi J; Miyazaki Y; Yoshida S; Fukushima T; Moriuchi Y; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M
Leukemia; 2000 Nov; 14(11):1861-6. PubMed ID: 11069020
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
[TBL] [Abstract][Full Text] [Related]
7. De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy.
Yoshida S; Kuriyama K; Miyazaki Y; Taguchi J; Fukushima T; Honda M; Hayashibara T; Nagai K; Atogami S; Toriya K; Soda H; Nonaka H; Momita S; Jinnai I; Amenomori T; Kusano M; Yoshida Y; Ikeda S; Matsuo T; Tomonaga M
Leuk Res; 2001 Jan; 25(1):33-38. PubMed ID: 11137558
[TBL] [Abstract][Full Text] [Related]
8. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand.
Auewarakul CU; Promsuwicha O; U-Pratya Y; Pattanapanyasat K; Issaragrisil S
Asian Pac J Allergy Immunol; 2003 Sep; 21(3):153-60. PubMed ID: 15032399
[TBL] [Abstract][Full Text] [Related]
10. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia.
Miyachi H; Tanaka Y; Gondo K; Kawada T; Kato S; Sasao T; Hotta T; Oshima S; Ando Y
Am J Hematol; 1999 Nov; 62(3):159-64. PubMed ID: 10539882
[TBL] [Abstract][Full Text] [Related]
12. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
13. The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype.
Matsuo T; Kuriyama K; Miyazaki Y; Yoshida S; Tomonaga M; Emi N; Kobayashi T; Miyawaki S; Matsushima T; Shinagawa K; Honda S; Ohno R;
Leukemia; 2003 Aug; 17(8):1538-43. PubMed ID: 12886240
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8].
Wang JH; Yao B; Guo M; Qiao JH; Sun QY; Hu KX; Li BX; Yu CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):655-61. PubMed ID: 27342486
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of acute myeloid leukemia and system Coulter VCS.
Bruno A; Del Poeta G; Venditti A; Stasi R; Adorno G; Aronica G; Suppo G; Di Rienzo AM; Iazzoni R; Tribalto M
Haematologica; 1994; 79(5):420-8. PubMed ID: 7843628
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol.
Wakui M; Kuriyama K; Miyazaki Y; Hata T; Taniwaki M; Ohtake S; Sakamaki H; Miyawaki S; Naoe T; Ohno R; Tomonaga M
Int J Hematol; 2008 Mar; 87(2):144-151. PubMed ID: 18256787
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
19. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig WD; Thiel E
Leuk Lymphoma; 1999 Jun; 34(1-2):85-94. PubMed ID: 10350335
[TBL] [Abstract][Full Text] [Related]
20. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F
Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
